We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $141M
1-Year Est. Return 190.82%
This Fund
S&P 500
This Quarter Est. Return
-15.54%
1 Year Est. Return
+190.82%
3 Year Est. Return
+375.7%
5 Year Est. Return
+81.85%
10 Year Est. Return
+4,735.29%
AUM
$258M
AUM Growth
-$84.7M
Cap. Flow
-$32.8M
Cap. Flow %
-12.7%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
2
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
VCYT icon
Veracyte
VCYT
+$32.1M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$718K
3
OPGN
OpGen, Inc
OPGN
+$40.1K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.68B
$174M 67.15%
4,233,870
-15,018
-0.4% -$718K
VCYT icon
2
Veracyte
VCYT
$4.44B
$28.9M 11.19%
1,205,407
-1,205,408
-50% -$32.1M
GRTS
3
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$26.8M 10.37%
3,102,929
– –
BOLD
4
DELISTED
Audentes Therapeutics, Inc
BOLD
$15.6M 6.02%
553,916
– –
OCUL icon
5
Ocular Therapeutix
OCUL
$1.85B
$6.73M 2.61%
2,215,384
– –
VANI icon
6
Vivani Medical
VANI
$113M
$3.71M 1.43%
187,207
– –
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$2.78M 1.08%
543,753
– –
CLVS
8
DELISTED
Clovis Oncology, Inc.
CLVS
$400K 0.15%
101,855
– –
OPGN
9
DELISTED
OpGen, Inc
OPGN
– –
-26
Closed -$40.1K

Similar funds

POIA
Pin Oak Investment Advisors Houston, Texas $141M AUM 20.83% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
TM
TFJ Management Somerville, Massachusetts $141M AUM 9.28% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
RB
Renasant Bank Tupelo, Mississippi $141M AUM 16.9% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
CFGW
Chancellor Financial Group WB Wilkes-Barre, Pennsylvania $141M AUM 23.22% 1-Year Est. Return

Versant Venture Management's Q3 2019 Portfolio in Review

As of Q3 2019, Versant Venture Management held 9 positions worth $258M, down 25% from $343M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Versant Venture Management withdrew a net $32.8M in Q3 2019, closing 1 position and reducing 2 holdings. Its most notable exit was OpGen, Inc, an estimated $40.1K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

  • Versant Venture Management's biggest Q3 2019 reduction was Veracyte, cutting an estimated $32.1M.
  • Versant Venture Management fully exited OpGen, Inc in Q3 2019, selling an estimated $40.1K.
  • Versant Venture Management's ten largest holdings make up 100% of its $258M portfolio in Q3 2019.
  • Versant Venture Management opened 0 new positions and closed 1 in Q3 2019.
  • Versant Venture Management's portfolio value fell 25% quarter-over-quarter to $258M.

Based on Versant Venture Management's 13F filing for Q3 2019, filed 8 Oct 2019.